Column Group LLC — 13F Holdings & Portfolio
CIK 1833486 · latest 13F-HR filed 2026-05-18
Column Group LLC manages $100.7M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are SRZNW (55.45%), ORIC (44.55%), RVMD (0.00%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 2, added to 3, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$100.7M
Long-equity book
3
Distinct positions
2026-03-31
Filed 2026-05-18
+0 / −2 / ↑3 / ↓0
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ORIC Pharmaceuticals Inc.$15.9M +54.9%
- Surrozen, Inc.$14.0M +33.5%
- Revolution Medicines Inc$810 +22.1%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-18 | $100.7M | 3 | 0001193125-26-227853 |
| 2025-12-31 | 2026-02-13 | $82.8M | 5 | 0001193125-26-051393 |
| 2025-09-30 | 2025-11-14 | $81.0M | 5 | 0001193125-25-282923 |